X-34, a fluorescent derivative of Congo red: A novel histochemical stain for Alzheimer's disease pathology

Journal of Histochemistry and Cytochemistry

Volumn 48, Issue 9, 2000, Pages 1223-1232

  Styren, S D ^a   Hamilton, R L ^a   Styren, G C ^a   Klunk, W E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Fluorescence microscopy; Neurofibrillary tangles; Neuropil threads; Plaques; Thioflavin S; X 34

Indexed keywords

CONGO RED; CONGO RED X34; FLUORESCENT DYE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIPOPHILICITY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0033857342     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540004800906     Document Type: Article

References (27)

1. The presence of ethylenic bonds and vic-glycol groups in neuromelanin and lipofuscin in the human brain
2. The oxidative generation of sulfonic acid groups in neuromelanin and lipofuscin in the human brain
3. Specific staining of amyloid by Congo red
4. In vivo multiphoton imaging of amyloid in mice transgenic for the human amyloid precursor protein. Soc Neurosci Abstr
5. The bases of the staining of amyloid fibers: Their physico- chemical nature and the mechanism of their dye-substrate interaction
6. The relation of the properties of Congo red-stained amyloid fibrils to the beta-conformation
7. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease
8. An improved immunohistostaining procedure for peptides in human brain
9. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody
10. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations
11. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids
12. Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease
13. Chrysamine G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe
14. Staining of AD and Tg2576 mouse brain with X-34, a highly fluorescent derivative of chrysamine G and a potential in vivo probe for beta-sheet fibrils
15. Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red-Aβ (CR-Aβ) spectrophotometric assay
16. Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acid
17. Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation
18. NMR identification of the formic acid-modified residue in Alzheimer's amyloid protein
19. Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions
20. On the binding of Congo red by amyloid
21. Quenching lipofuschin autofluorescence in aged and Alzheimer's brain: A double-label fluorescence method with thioflavin counterstain
22. Rapid expression and transport of embryonic N-CAM in dentate gyrus following entorhinal cortex lesion: Ultrastructural analysis
23. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease
24. Comparison of four staining methods on the detection of neuritic plaques
25. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain
26. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles